CoChat

The CRL4Cdt2 ubiquitin ligase targets the degradation of p21Cip1 to control replication licensing

Open access
Kim, Youngjo, Starostina, Natalia G., Kipreos, Edward T. · 2008 · Genes & Development

The DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index.

Abstract

The faithful replication of genomic DNA is crucial for maintaining genome stability. In eukaryotes, DNA rereplication is prevented by the temporal regulation of replication licensing. Replication-licensing factors are required to form prereplicative complexes during G1 phase, but are inactivated in S phase to prevent rereplication. A vertebrate CUL4 CRL ubiquitin ligase (CRL4) complex containing Cdt2 as the substrate recognition subunit promotes proper DNA replication, in part, by degrading the replication-licensing factor Cdt1 during S phase. We show that the Caenorhabditis elegans CRL4(Cdt2) complex has a conserved role in degrading Cdt1. Furthermore, we show that CRL4(Cdt2) restrains replication licensing in both C. elegans and humans by targeting the degradation of the cyclin-dependent kinase (CDK) inhibitors CKI-1 and p21(Cip1), respectively. Human CRL4(Cdt2) targets the degradation of p21 in S phase, with the in vivo ubiquitylation of p21 by CRL4(Cdt2) dependent on p21 binding to PCNA. Inactivation of Cdt2 induces rereplication, which requires the presence of the CDK inhibitor p21. Strikingly, coinactivation of CRL4(Cdt2) and SCF(Skp2) (which redundantly targets p21 degradation) prevents the nuclear export of the replication-licensing factor Cdc6 during S phase, and the block on nuclear export is dependent on p21. Our work defines the degradation of p21 as a critical aspect of replication licensing in human cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/gad.1703708

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 56 references

Research works printed but not linked: 1

  1. Ausubel, F.M. Brent, R. Kingston, R.E. Moore, D.D. Seidman, J.G. Smith, J.A. Struhl, K. , eds(1994) Current protocols in molecular biology, Saccharomyces cerevisiae (Wiley, New York) In, pp 13.0.1–13.14.17.

Cited by

See all 243

Metadata

Authors
Kim, Y., Starostina, N. G., & Kipreos, E. T.
Affiliations
University of Georgia (US)
Venue
Genes & Development
Published
2008-09-15
Volume
22
Issue
18
Pages
2507-2519
ISSN
  • 0890-9369 (ISSN-L)
  • 1549-5477
OpenAlex
W2161618888
Cited by
240
References
57
Citations by year
2026: 7 · 2025: 5 · 2024: 10 · 2023: 3 · 2022: 9 · 2021: 10 · 2020: 10 · 2019: 13 · 2018: 9 · 2017: 15 · 2016: 11 · 2015: 11 · 2014: 20 · 2013: 13 · 2012: 30
Type
posted content
Language
en
Open access
Locations
  • Genes & Development (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
  • National Institutes of Health
  • National Institute of General Medical Sciences (R01GM055297, R01GM074212)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords
p21, replication licensing, DNA re-replication, PCNA, CUL4A, CUL4B, ubiquitination, pre-replication complex, genome stability, S phase
MeSH terms
Animals, Base Sequence, Cell Line, DNA Replication, Humans, Hydrolysis, Caenorhabditis elegans, RNA, Small Interfering, Ubiquitin-Protein Ligases, Cyclin-Dependent Kinase Inhibitor p21, Ubiquitination

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The CRL4Cdt2 ubiquitin ligase targets the degradation of p21Cip1 to control replication licensing. https://app.cochat.ai/papers/10.1101/gad.1703708
The paper
Kim, Y., Starostina, N. G., & Kipreos, E. T. (2008). The CRL4Cdt2 ubiquitin ligase targets the degradation of p21Cip1 to control replication licensing. Genes & Development. https://doi.org/10.1101/gad.1703708

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.